Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shepherd

Showing results (61-70 of 1,465) with videos related to

Pageof 147
Sort By:
Oncology (Williston Park, N.Y.)|September 2, 2004
Current paradigms in first-line treatment of non-small-cell lung cancerFrances A Shepherd
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? Yes, there is a role for EGFR TKIs in these patientsFrances A Shepherd
British Medical Journal (Clinical Research Ed.)|May 8, 1982
Lawson Tait-disciple of Charles DarwinJ A Shepherd
Current Opinion in Oncology|March 1, 1993
Screening, diagnosis, and staging of lung cancerF A Shepherd
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2010
Surgery for limited stage small cell lung cancer: time to fish or cut baitFrances A Shepherd
The British Journal of Surgery|March 19, 2010
Constriction of the extensor pollicis brevis tendon; an unusual lesion simulating de Quervain's diseaseJ A SHEPHERD
Expert Review of Anticancer Therapy|August 26, 2003
Second-line chemotherapy for non-small cell lung cancerFrances A Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Maintenance therapy comes of age for non-small-cell lung cancer, but at what cost?Frances A Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Chemotherapy for advanced non-small-cell lung cancer: modest progress, many choicesF A Shepherd
Seminars in Oncology|June 1, 1994
Future directions in the treatment of non-small cell lung cancerF A Shepherd
Pageof 147

Showing results (61-70 of 1,465) with videos related to

Sort By:
Pageof 147
Oncology (Williston Park, N.Y.)|September 2, 2004
Current paradigms in first-line treatment of non-small-cell lung cancerFrances A Shepherd
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? Yes, there is a role for EGFR TKIs in these patientsFrances A Shepherd
British Medical Journal (Clinical Research Ed.)|May 8, 1982
Lawson Tait-disciple of Charles DarwinJ A Shepherd
Current Opinion in Oncology|March 1, 1993
Screening, diagnosis, and staging of lung cancerF A Shepherd
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2010
Surgery for limited stage small cell lung cancer: time to fish or cut baitFrances A Shepherd
The British Journal of Surgery|March 19, 2010
Constriction of the extensor pollicis brevis tendon; an unusual lesion simulating de Quervain's diseaseJ A SHEPHERD
Expert Review of Anticancer Therapy|August 26, 2003
Second-line chemotherapy for non-small cell lung cancerFrances A Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Maintenance therapy comes of age for non-small-cell lung cancer, but at what cost?Frances A Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Chemotherapy for advanced non-small-cell lung cancer: modest progress, many choicesF A Shepherd
Seminars in Oncology|June 1, 1994
Future directions in the treatment of non-small cell lung cancerF A Shepherd
Pageof 147